{
  "report_rows": [
    {
      "kpi": "Total revenue",
      "prediction": "IN-LINE",
      "answer": "pred ~$1.301B vs. cons $1.294B",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Total bookings",
      "prediction": "IN-LINE",
      "answer": "pred ~$1.431B vs. cons $1.425B",
      "confidence": "LOW"
    },
    {
      "kpi": "Normalized EBITDA",
      "prediction": "IN-LINE",
      "answer": "pred ~$432M vs. cons $428M",
      "confidence": "MEDIUM"
    }
  ],
  "guide_rows": [
    {
      "kpi": "3Q26 total-revenue guidance",
      "prediction": "LOWER",
      "answer": "guide ~$1.305B vs. cons $1.318B (3Q26)",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "FY26 total-revenue guidance midpoint",
      "prediction": "LOWER",
      "answer": "guide ~$5.235B vs. cons $5.280B (FY26)",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "FY26 free-cash-flow guidance",
      "prediction": "LOWER",
      "answer": "guide ~$1.800B vs. cons $1.820B (FY26)",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "FY26 normalized EBITDA margin",
      "prediction": "UNCHANGED",
      "answer": "guide ~33.1% vs. cons 33.1% (FY26)",
      "confidence": "MEDIUM"
    }
  ],
  "day1_residual_pct": -4,
  "day1_confidence": "MEDIUM",
  "day5_residual_pct": -5.5,
  "day5_path": "FOLLOW-THROUGH",
  "day5_rationale": "A modest ~$1.301B revenue result versus ~$1.294B consensus and ~$432M EBITDA versus ~$428M consensus is unlikely to offset a ~ $1.305B 3Q26 revenue guide versus ~$1.318B consensus; unchanged ~$5.235B FY26 revenue and ~$1.800B FCF targets imply out-period estimate cuts.",
  "day5_confidence": "MEDIUM"
}